Steven Chamow

Advised and coordinated functions including manufacturing sciences, manufacturing operations, supply chain and validations. Ensured coordination with quality and adherence to manufacturing s...

Direct CMC development of monoclonal antibody therapeutics for infectious disease.

President of San Francisco Bay Area biologics CMC consulting group and principal consultant for biotechnology companies involved in the development of biologics as human therapeutics. More t...

A pre-clinical stage, privately held company pioneering the use of RNAi as a human therapeutic. The technology involves formulating RNAi as a targeted, polymer-based nanoparticle for systemi...

Established process sciences department to transition the MyVax® (an autologous recombinant antibody-KLH conjugate vaccine for treatment of follicular non-Hodgkins lymphoma) clinical process...

Initiated in 2000 the design of $140M, state-of-the-art facilities for production of recombinant human antibody therapeutics. Established process sciences department to develop vial-to-vial ...

Responsible for all process development and clinical manufacturing of the company’s protein biotherapeutics. Oversaw conformance manufacturing campaign with European contract manufacturer to...

DEVELOPMENT: Designed downstream process for large-scale production of anti-VEGF mAb (Avastin) for clinical testing. Avastin was approved in 2004. Led the manufacturing subteam and coordinat...

NIH/NIDDK, Laboratory of Cellular and Developmental Biology. Project: First cloning of egg surface receptor for sperm in a mammal. Proof of concept for a contraceptive vaccine based on clone...